These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 12393996)

  • 1. Carboplatin and vinblastine for the treatment of metastatic transitional cell carcinoma of the urothelial tract.
    Al-Karim HA; Tan KE; Chi KN; Bryce CJ; Murray NR; Coppin C
    Am J Clin Oncol; 2002 Oct; 25(5):515-9. PubMed ID: 12393996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized phase II/III trial assessing gemcitabine/ carboplatin and methotrexate/carboplatin/vinblastine in patients with advanced urothelial cancer "unfit" for cisplatin-based chemotherapy: phase II--results of EORTC study 30986.
    De Santis M; Bellmunt J; Mead G; Kerst JM; Leahy M; Maroto P; Skoneczna I; Marreaud S; de Wit R; Sylvester R
    J Clin Oncol; 2009 Nov; 27(33):5634-9. PubMed ID: 19786668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. M-VECA (methotrexate, vinblastine, epidoxorubicin and carboplatin) in the treatment of advanced urothelial carcinoma.
    Lorusso V; Berardi F; Brandi M; Mastria A; Paradiso A; Catino AM; Tatulli C; De Lena M
    Tumori; 1993 Jun; 79(3):191-4. PubMed ID: 8236502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Southwest Oncology Group Study of paclitaxel and carboplatin for advanced transitional-cell carcinoma: the importance of survival as a clinical trial end point.
    Small EJ; Lew D; Redman BG; Petrylak DP; Hammond N; Gross HM; Eastham JA; Crawford ED
    J Clin Oncol; 2000 Jul; 18(13):2537-44. PubMed ID: 10893284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salvage treatment with low-dose weekly paclitaxel in elderly or poor performance status patients with metastatic urothelial carcinoma.
    Han JJ; Kim YJ; Kim JW; Chang H; Lee JO; Lee KW; Jeong CW; Kim JH; Hong SK; Bang SM; Byun SS; Lee SE; Lee JS
    Tumori; 2014; 100(4):439-45. PubMed ID: 25296594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gemcitabine and carboplatin in advanced transitional cell carcinoma of the urinary tract: an alternative therapy.
    Nogué-Aliguer M; Carles J; Arrivi A; Juan O; Alonso L; Font A; Mellado B; Garrido P; Sáenz A;
    Cancer; 2003 May; 97(9):2180-6. PubMed ID: 12712469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II trial of intermediate dose methotrexate in combination with vinblastine, doxorubicin, and cisplatin in patients with unresectable or metastatic transitional cell carcinoma.
    Dodd PM; McCaffrey JA; Mazumdar M; Scher H; Vlamis V; Higgins G; Herr H; Bajorin DF
    Cancer; 1999 Mar; 85(5):1145-50. PubMed ID: 10091800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitomycin C, vinblastine, and carboplatin regimen in patients with nonsmall cell lung cancer. A phase II trial.
    Paccagnella A; Favaretto A; Oniga F; Festi G; Lauro S; Morabito A; Ossana L; Sartore F; DePoli F; Fiorentino MV
    Cancer; 1996 Oct; 78(8):1701-7. PubMed ID: 8859183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A carboplatin-based regimen for the treatment of patients with advanced transitional cell carcinoma of the urothelium.
    Small EJ; Fippin LJ; Ernest ML; Carroll PR
    Cancer; 1996 Oct; 78(8):1775-80. PubMed ID: 8859191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II trial of carboplatin and paclitaxel in cisplatin-pretreated advanced transitional cell carcinoma: a Southwest Oncology Group study.
    Vaishampayan UN; Faulkner JR; Small EJ; Redman BG; Keiser WL; Petrylak DP; Crawford ED
    Cancer; 2005 Oct; 104(8):1627-32. PubMed ID: 16138364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase III trial of methotrexate, vinblastine, doxorubicin, and cisplatin versus carboplatin and paclitaxel in patients with advanced carcinoma of the urothelium.
    Dreicer R; Manola J; Roth BJ; See WA; Kuross S; Edelman MJ; Hudes GR; Wilding G
    Cancer; 2004 Apr; 100(8):1639-45. PubMed ID: 15073851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II trial of weekly paclitaxel and carboplatin chemotherapy in patients with advanced transitional cell cancer.
    Johannsen M; Sachs M; Roigas J; Hinke A; Staack A; Loening SA; Schnorr D; Wille AH
    Eur Urol; 2005 Aug; 48(2):246-51. PubMed ID: 15963636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Our experience with 23 consecutive patients on gemcitabine/carboplatin chemotherapy for treatment of metastasized transitional cell carcinoma of the urothelium.
    Hoschke B; May M; Seehafer M; Helke C
    Int J Urol; 2004 Jul; 11(7):461-6. PubMed ID: 15242353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carboplatin, methotrexate, and vinblastine in the treatment of patients with advanced urothelial cancer. A phase II trial.
    Boccardo F; Pace M; Guarneri D; Canobbio L; Curotto A; Martorana G
    Cancer; 1994 Apr; 73(7):1932-6. PubMed ID: 8137220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination chemotherapy with carboplatin and methotrexate in the treatment of advanced urothelial carcinoma. A phase II study.
    Dogliotti L; Bertetto O; Berruti A; Clerico M; Fanchini L; Sicora W; Faggiuolo R
    Am J Clin Oncol; 1995 Feb; 18(1):78-82. PubMed ID: 7847264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multicenter Phase 2 Trial of Gemcitabine, Carboplatin, and Sorafenib in Patients With Metastatic or Unresectable Transitional-Cell Carcinoma.
    Hurwitz ME; Markowski P; Yao X; Deshpande H; Patel J; Mortazavi A; Donadio A; Stein MN; Kelly WK; Petrylak DP; Mehnert JM
    Clin Genitourin Cancer; 2018 Dec; 16(6):437-444.e6. PubMed ID: 30177237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ifosfamide, paclitaxel, and cisplatin for patients with advanced transitional cell carcinoma of the urothelial tract: final report of a phase II trial evaluating two dosing schedules.
    Bajorin DF; McCaffrey JA; Dodd PM; Hilton S; Mazumdar M; Kelly WK; Herr H; Scher HI; Icasiano E; Higgins G
    Cancer; 2000 Apr; 88(7):1671-8. PubMed ID: 10738226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapy with cisplatin, epirubicin and docetaxel in transitional cell urothelial cancer. Phase II trial.
    Pectasides D; Visvikis A; Aspropotamitis A; Halikia A; Karvounis N; Dimitriadis M; Athanassiou A
    Eur J Cancer; 2000 Jan; 36(1):74-9. PubMed ID: 10741298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of advanced urothelial carcinoma with M-VECA (methotrexate, vinblastine, epirubicin and carboplatin).
    Lorusso V; Pagliarulo A; Selvaggi FP; Durini E; Riccardi F; Comella P; Fiorillo C; De Lena M
    J Chemother; 1996 Apr; 8(2):154-8. PubMed ID: 8708748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced transitional cell carcinoma of the urothelium. Efficacy and patterns of response and relapse.
    Sternberg CN; Yagoda A; Scher HI; Watson RC; Geller N; Herr HW; Morse MJ; Sogani PC; Vaughan ED; Bander N
    Cancer; 1989 Dec; 64(12):2448-58. PubMed ID: 2819654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.